CorMedix Inc.
CRMD
$8.13
-$0.05-0.61%
NASDAQ
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Revenue | 462.25M | 400.05M | 311.71M | 214.30M | 121.48M |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 462.25M | 400.05M | 311.71M | 214.30M | 121.48M |
| Cost of Revenue | 45.24M | 32.55M | 22.09M | 12.04M | 5.11M |
| Gross Profit | 417.00M | 367.50M | 289.62M | 202.26M | 116.37M |
| SG&A Expenses | 127.80M | 116.16M | 96.07M | 82.06M | 58.76M |
| Depreciation & Amortization | 34.37M | 24.12M | 13.87M | 3.78M | 208.00K |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 235.01M | 196.18M | 151.37M | 110.35M | 72.17M |
| Operating Income | 227.24M | 203.87M | 160.34M | 103.95M | 49.32M |
| Income Before Tax | 203.40M | 185.02M | 150.02M | 107.03M | 51.68M |
| Income Tax Expenses | 16.23M | 4.01M | -13.04M | -55.47M | 521.80K |
| Earnings from Continuing Operations | 187.17 | 181.01 | 163.06 | 162.50 | 51.16 |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | 187.17M | 181.01M | 163.06M | 162.50M | 51.16M |
| EBIT | 227.24M | 203.87M | 160.34M | 103.95M | 49.32M |
| EBITDA | 262.55M | 228.81M | 174.89M | 108.20M | 49.85M |
| EPS Basic | 2.41 | 2.37 | 2.20 | 2.26 | 0.78 |
| Normalized Basic EPS | 1.81 | 1.66 | 1.35 | 0.95 | 0.49 |
| EPS Diluted | 2.14 | 2.12 | 1.99 | 2.05 | 0.74 |
| Normalized Diluted EPS | 1.55 | 1.43 | 1.20 | 0.88 | 0.47 |
| Average Basic Shares Outstanding | 312.72M | 302.21M | 287.94M | 270.61M | 253.51M |
| Average Diluted Shares Outstanding | 365.60M | 345.04M | 321.03M | 288.62M | 261.23M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |